Bashashati M et al. |
Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation. |
2015 |
Br. J. Pharmacol. |
pmid:25684407
|
Szekeres M et al. |
Endocannabinoid-mediated modulation of Gq/11 protein-coupled receptor signaling-induced vasoconstriction and hypertension. |
2015 |
Mol. Cell. Endocrinol. |
pmid:25595485
|
Thieme U et al. |
Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans. |
2014 Jan-Feb |
Drug Test Anal |
pmid:24424856
|
Shonesy BC et al. |
Genetic disruption of 2-arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation. |
2014 |
Cell Rep |
pmid:25466252
|
Gasperi V et al. |
2-Arachidonoylglycerol enhances platelet formation from human megakaryoblasts. |
2014 |
Cell Cycle |
pmid:25427281
|
Zhang J et al. |
Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer's disease. |
2014 |
J. Neurosci. |
pmid:25378159
|
Fezza F et al. |
Endocannabinoids, related compounds and their metabolic routes. |
2014 |
Molecules |
pmid:25347455
|
Smaga I et al. |
Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures. |
2014 |
Neurotox Res |
pmid:24652522
|
Karabowicz P et al. |
[Role of endocannabinoid 2-arachidonoylglycerol in the physiology and pathophysiology of the cardiovascular system]. |
2014 |
Postepy Hig Med Dosw (Online) |
pmid:24934539
|
Hillard CJ |
Stress regulates endocannabinoid-CB1 receptor signaling. |
2014 |
Semin. Immunol. |
pmid:24882055
|
Kohnz RA and Nomura DK |
Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids. |
2014 |
Chem Soc Rev |
pmid:24676249
|
Pastor A et al. |
Analysis of ECs and related compounds in plasma: artifactual isomerization and ex vivo enzymatic generation of 2-MGs. |
2014 |
J. Lipid Res. |
pmid:24610889
|
Stanley CP and O'Sullivan SE |
Cyclooxygenase metabolism mediates vasorelaxation to 2-arachidonoylglycerol (2-AG) in human mesenteric arteries. |
2014 |
Pharmacol. Res. |
pmid:24548820
|
Pérez-Morales M et al. |
2-Arachidonoylglycerol into the lateral hypothalamus improves reduced sleep in adult rats subjected to maternal separation. |
2014 |
Neuroreport |
pmid:25356522
|
Signorello MG and Leoncini G |
Effect of 2-arachidonoylglycerol on myosin light chain phosphorylation and platelet activation: The role of phosphatidylinositol 3 kinase/AKT pathway. |
2014 |
Biochimie |
pmid:25068972
|
Fernández-Suárez D et al. |
Monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model. |
2014 |
Neurobiol. Aging |
pmid:24973119
|
Petrenko AB et al. |
Augmented tonic pain-related behavior in knockout mice lacking monoacylglycerol lipase, a major degrading enzyme for the endocannabinoid 2-arachidonoylglycerol. |
2014 |
Behav. Brain Res. |
pmid:24906199
|
Tsurumura T and Tsuge H |
Substrate selectivity of bacterial monoacylglycerol lipase based on crystal structure. |
2014 |
J. Struct. Funct. Genomics |
pmid:24894647
|
Alhouayek M et al. |
Controlling 2-arachidonoylglycerol metabolism as an anti-inflammatory strategy. |
2014 |
Drug Discov. Today |
pmid:23891880
|
Morena M et al. |
Endogenous cannabinoid release within prefrontal-limbic pathways affects memory consolidation of emotional training. |
2014 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:25489086
|
Khasabova IA et al. |
JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy. |
2014 |
Pharmacol. Res. |
pmid:25304184
|
Wiley JL et al. |
Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents. |
2014 |
Eur. J. Pharmacol. |
pmid:24858366
|
Navarria A et al. |
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis. |
2014 |
Pharmacol. Res. |
pmid:24861565
|
Nader J et al. |
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors. |
2014 |
Neuropharmacology |
pmid:24709540
|
Sun LJ et al. |
Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication. |
2014 |
Int. J. Infect. Dis. |
pmid:24704332
|
Basavarajappa BS et al. |
Elevation of endogenous anandamide impairs LTP, learning, and memory through CB1 receptor signaling in mice. |
2014 |
Hippocampus |
pmid:24648181
|
Oleson EB et al. |
Cannabinoid receptor activation shifts temporally engendered patterns of dopamine release. |
2014 |
Neuropsychopharmacology |
pmid:24345819
|
Aaltonen N et al. |
Brain regional cannabinoid CB(1) receptor signalling and alternative enzymatic pathways for 2-arachidonoylglycerol generation in brain sections of diacylglycerol lipase deficient mice. |
2014 |
Eur J Pharm Sci |
pmid:24012970
|
Brantl SA et al. |
Activation of platelets by the endocannabinoids 2-arachidonoylglycerol and virodhamine is mediated by their conversion to arachidonic acid and thromboxane A2, not by activation of cannabinoid receptors. |
2014 |
Platelets |
pmid:24102401
|
Brantl SA et al. |
Mechanism of platelet activation induced by endocannabinoids in blood and plasma. |
2014 |
Platelets |
pmid:23789792
|
Iannotti FA et al. |
The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kv7 channels. |
2014 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:24927567
|
Tiburu EK and Shen L |
Distance measurements and conformational analysis of sn-2-arachidonoylglycerol-membrane sample by ²H-³¹P REDOR NMR. |
2014 |
J. Membr. Biol. |
pmid:24402242
|
Costa MA et al. |
2-arachidonoylglycerol effects in cytotrophoblasts: metabolic enzymes expression and apoptosis in BeWo cells. |
2014 |
Reproduction |
pmid:24324206
|
Pertwee RG |
Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications. |
2014 |
Proc Nutr Soc |
pmid:24135210
|
Burston JJ and Woodhams SG |
Endocannabinoid system and pain: an introduction. |
2014 |
Proc Nutr Soc |
pmid:24148358
|
Desroches J et al. |
Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CBâ‚ and CBâ‚‚ receptors. |
2014 |
Neuropharmacology |
pmid:24148808
|
Yang K et al. |
Differential regulation of NMDAR and NMDAR-mediated metaplasticity by anandamide and 2-AG in the hippocampus. |
2014 |
Hippocampus |
pmid:25087967
|
Fezza F et al. |
Distinct modulation of the endocannabinoid system upon kainic acid-induced in vivo seizures and in vitro epileptiform bursting. |
2014 |
Mol. Cell. Neurosci. |
pmid:25064144
|
Pulgar VM et al. |
Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis. |
2014 |
Hypertension |
pmid:24935942
|
Jergas B et al. |
O-2050 facilitates noradrenaline release and increases the CB1 receptor inverse agonistic effect of rimonabant in the guinea pig hippocampus. |
2014 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:24853577
|
Pava MJ et al. |
Endocannabinoid modulation of cortical up-states and NREM sleep. |
2014 |
PLoS ONE |
pmid:24520411
|
Sanson B et al. |
Crystallographic study of FABP5 as an intracellular endocannabinoid transporter. |
2014 |
Acta Crystallogr. D Biol. Crystallogr. |
pmid:24531463
|
Fowler CJ |
Has FLAT fallen flat? |
2014 |
Trends Pharmacol. Sci. |
pmid:24398120
|
Nicolussi S et al. |
Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice. |
2014 |
Pharmacol. Res. |
pmid:24412246
|
Bystrowska B et al. |
Changes in endocannabinoid and N-acylethanolamine levels in rat brain structures following cocaine self-administration and extinction training. |
2014 |
Prog. Neuropsychopharmacol. Biol. Psychiatry |
pmid:24334211
|
Schaefer C et al. |
Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders. |
2014 |
Eur Arch Psychiatry Clin Neurosci |
pmid:24253425
|
Limebeer CL et al. |
Attenuation of anticipatory nausea in a rat model of contextually elicited conditioned gaping by enhancement of the endocannabinoid system. |
2014 |
Psychopharmacology (Berl.) |
pmid:24043345
|
Kim J and Watkins BA |
Cannabinoid receptor antagonists and fatty acids alter endocannabinoid system gene expression and COX activity. |
2014 |
J. Nutr. Biochem. |
pmid:24854955
|
Alpár A et al. |
Endocannabinoids modulate cortical development by configuring Slit2/Robo1 signalling. |
2014 |
Nat Commun |
pmid:25030704
|
Manna JD et al. |
Identification of the major prostaglandin glycerol ester hydrolase in human cancer cells. |
2014 |
J. Biol. Chem. |
pmid:25301951
|